GlassScriptPhysician profile
Sandeep Chowdhary
NPI 1891726162
$6,593.34
in general payments reported to CMS, 2019-2025
42 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $961 · 2020: $301 · 2021: $859 · 2022: $766 · 2023: $821 · 2024: $1,490 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,689 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,688.80 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $734.71 | 2019-2025 | Airsupra, Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $522.03 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $504.48 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $455.03 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Mylan Specialty L.P. | $404.86 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $398.04 | 2020-2025 | Wakix |
| Insmed, INC. | $364.39 | 2019-2025 | Arikayce, Brinsupri |
| Inspire Medical Systems, INC. | $285.93 | 2023-2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $204.37 | 2019-2025 | |
| Grifols USA, LLC | $204.07 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $201.58 | 2021-2025 | |
| Genzyme Corporation | $201.07 | 2019-2025 | |
| Pulmonx Corporation | $191.69 | 2022-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Actelion Pharmaceuticals US, INC. | $181.46 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $152.87 | 2019-2025 | Winrevair, Belsomra |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $152.59 | 2019-2024 | |
| Baxter Healthcare | $151.23 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Sunovion Pharmaceuticals INC. | $122.58 | 2019-2020 | |
| Resmed Corp | $108.36 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $96.00 | 2024 | Acthar |
| Teva Pharmaceuticals USA, INC. | $95.58 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.87 | 2021-2025 | Glassia |
| Avadel Cns Pharmaceuticals, LLC | $83.43 | 2024-2025 | Lumryz |
| Regeneron Healthcare Solutions, INC. | $79.19 | 2022-2025 | Dupixent |
| Viatris Specialty LLC | $76.25 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $70.25 | 2023-2024 | Quviviq |
| Electromed, INC. | $67.06 | 2019-2024 | Smartvest |
| Genentech USA, INC. | $61.18 | 2019 | |
| Axsome Therapeutics, INC. | $54.90 | 2023-2025 | Sunosi |
| Fisher & Paykel Healthcare INC | $41.70 | 2021-2024 | Fisher & Paykel Healthcare |
| Verona Pharma, INC. | $38.29 | 2025 | Ohtuvayre |
| Arbor Pharmaceuticals, INC. | $36.36 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $25.21 | 2024 | Purified Cortrophin Gel |
| Itamar Medical INC | $23.76 | 2024 | Watchpatone |
| Boston Scientific Corporation | $16.81 | 2023 | |
| Astellas Pharma US INC | $15.89 | 2024 | Cresemba |
| Abbvie INC. | $15.32 | 2023 | Avycaz |
| Nalpropion Pharmaceuticals LLC | $14.54 | 2019 | |
| Inogen, INC. | $14.46 | 2021 | |
| Shire North American Group INC | $13.51 | 2019 | |
| Philips North America LLC | $12.84 | 2023 | |
| Circassia INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Chowdhary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.